Intratumoral Anti-PD-1 Nanoformulation Improves Its Biodistribution.
Sign Up to like & getrecommendations! Published in 2022 at "ACS applied materials & interfaces"
DOI: 10.1021/acsami.1c22479
Abstract: Intratumoral administration of immune checkpoint inhibitors, such as programmed cell death-1 antibodies (aPD-1), is a promising approach toward addressing both the low patients' responses and high off-target toxicity, but good preclinical results have not translated… read more here.
Keywords: free apd; intratumoral administration; intratumoral anti; apd ... See more keywords